AI-focused episodes of Moonshots with Peter Diamandis - exponential tech, longevity, and the future of intelligence.

Kimmy K3, the largest AI model to date, launched and rapidly became the top model globally. The model is a multimodal and has outperformed existing models like Claude Fable 5. China's advancements in AI are occurring despite U.S. export controls on advanced technology.

Mira Murati launched Inkling, a customizable AI model aimed at market needs. Ramin Hasani discusses the concept of liquid AI and the future of small language models. Demis Hassabis advocates for a US-led AI regulatory body similar to FINRA.

Elon Musk announced Grok 4.5 on July 8, followed by OpenAI's release of GPT 5.6 on July 9. Apple has filed a lawsuit against OpenAI for alleged trade secret theft amid their shifting relationship. China has made strides in rocket technology with the successful landing of an orbital booster.

Fable 5 has returned online globally with new safety measures for government compliance. Sam Altman proposed a 5% equity deal for OpenAI valued at approximately $42.6 billion. Anthropic's research claims to have found signs of consciousness in its model Claude. The podcast discusses the latest trends in AI investment and innovation.

Sonnet 5 is filling the gap until Fable 5 returns. Fable 5 has been offline due to regulatory issues but may return soon. Helion has received regulatory approval for its Orion Fusion power plant. Exponential growth in sectors like solar and EVs is often underestimated by experts. The Moonshots podcast covers various advancements in robotics and energy.

US government imposes national security hold on AI products. OpenAI delays GPT 5.6 release and IPO due to regulatory concerns. Anthropic accuses Alibaba of AI technology theft, signaling escalating global tensions.

Planet is a $10 billion company focusing on planetary intelligence through large earth models. China's GLM 5.2 model is emerging as a competitive player in AI, matching OpenAI's top models. The integration of satellite data and AI aims to enhance understanding of the planet's dynamics.

SpaceX completes the world's largest IPO at a $2.89T valuation. Elon Musk becomes the world's first trillionaire as a result. US government suspends AI models Fable 5 and Mythos 5 for foreign access. Discussion around the control of AI and potential delays on OpenAI's IPO.

City Bank predicts Bitcoin could reach $189,000 by 2026. Anthropic's new releases, Fable 5 and Mythos 5, position the company as a leader in AI. NewLimit raises $435 million to advance age-reversal technology.

Anthropic claims over 80% of their code is now generated by their AI, Claude. Argentina is positioning itself as a global AI haven with new legal frameworks. Anthropic calls for a temporary global pause on frontier AI development.

Anthropic files for a $965 billion IPO, potentially the first major AI lab to go public. Trump signs an executive order promoting AI innovation without heavy regulation. ChatGPT surpasses 1 billion monthly active users, marking unprecedented growth.

AGI is expected to be achieved by 2029. Significant progress in AI has occurred in only the last six months. Ray Kurzweil emphasizes the importance of understanding human language in AI development. Historical predictions about AI have often been accurate, with Kurzweil maintaining an 86% accuracy rate.

Anthropic's Opus 4.8 surpasses OpenAI's GPT 5.5 in coding benchmarks. OpenAI is building the largest philanthropic fund to promote global peace and prosperity. Demis Hassabis predicts AGI by 2029 alongside Ray Kurzweil.

Pope Leo I 14th issues a significant encyclical on AI risks and ethical considerations. GPT 5.5 outperforms Claude Opus 4.7 in coding benchmarks. Sam Altman revises previous doomsday predictions regarding AI-induced job displacement.

AI is fundamentally reshaping organizational structures. Companies must transition to AI-native models or face disruption. New organizational designs should prioritize intelligence over hierarchy. Survival in business will depend on adaptability in the coming years. Strategies for transformation are crucial for all types of organizations.

SpaceX filed for a historic IPO aiming to raise over $75 billion. GPT 5.5 outperformed prediction markets in forecasting the Super Bowl. AI has solved an 80-year-old math problem, marking a significant milestone.

Google's capital expenditure has dramatically increased, leading to a rise in stock value. Andre Karpathy has joined Anthropic to enhance Claude's pre-training research. Cerebras announced a record $95 billion IPO, marking a significant achievement in the tech industry.

Anthropic takes over SpaceX's Colossus 1 data center, doubling Claude's code rate limits. Leopold Ashen Brener, ex-OpenAI, now runs a $5.5 billion fund aimed at AI investment. Anthropic achieves astonishing 80x growth this quarter, potentially reaching a $40 trillion valuation by 2027. Discussion includes trends in AI demand and the upcoming 'singularity economy' offering outsized financial returns.

Google's earnings reached $109.9 billion, a 22% growth year-on-year. The White House is exploring vetting AI models, raising concerns about stifling competition. AI is significantly driving growth across Google's ecosystem. The Moonshots gathering is set for September 25th in Los Angeles.

Demis Hassabis argues that achieving AGI may not require a major breakthrough. Production of humanoid robots is rapidly increasing, with ambitious targets set for the next few years. There are predictions of up to 10 billion humanoid robots by 2040.

Google invests $40 billion into Anthropic. OpenAI releases GPT 5.5, enhancing its codecs. Google Cloud launches eighth-generation TPUs for AI processing. AI model releases are rapidly increasing, with two major releases per week.

GLP-1 medications show heart and brain benefits beyond weight loss. AI is transforming drug design, potentially reversing aging. Addressing the Hayflick limit may extend cellular lifespan. GLP-1 side effect: rare blindness cases linked to the drug. Stress in plants may enhance health benefits through xenohormesis.

David Sinclair is about to begin the first human trial for epigenetic reprogramming to cure blindness. The research uses a subset of Yamanaka genes, showing promise for reversing aging across various body tissues. Future applications may include treatments for ALS, memory improvement, and overall longevity.

Elon Musk's SpaceX negotiates a $60B deal to acquire Cursor, signaling major industry shifts. AI startups are rapidly emerging, challenging established companies in their adoption of AI. The geopolitical landscape is volatile, particularly due to tensions in Iran, affecting global markets. The Breakthrough Prize celebrated significant scientific advancements, resembling an 'Oscars of science.' Sam Altman and other tech leaders are likely to appear on future podcasts, discussing industry developments.

Sam Altman faced an attack leading to discussions on AI's societal implications. Anthropic's Opus 4.7 release is seen as solid but lacks the excitement of previous versions. Amazon and Apple are poised to compete against SpaceX's Starlink. Public sentiment towards AI remains low with only 23% optimistic. New AI models emphasize the use of prompts over traditional hyperparameters.

Elon Musk has sued OpenAI for $100 billion amidst intense rivalry. OpenAI's valuation reached $852 billion, highlighting exponential growth in AI investment. The potential for AI to replace white collar jobs is imminent, with significant implications for the workforce.

SpaceX is set to go public with a valuation of $2 trillion. Starlink accounts for 75-80% of SpaceX's valuation, highlighting its success. Anthropic's new AI model Mythos is considered too capable for public release.

Colossal aims to bring back extinct species like the woolly mammoth using AI and synthetic biology. The company has spun out multiple ventures, including Breaking, which focuses on plastic degradation. AI is integral to all the company's projects, enhancing capabilities in designing and building living products.
1:30:00Three medical-AI founders discuss the realistic 5-year path for AI in healthcare with refreshingly little hype. Consensus: AI augments rather than replaces, but the day-to-day work itself changes substantially. Concrete bottlenecks: multi-site data access, regulatory alignment across jurisdictions, and clinician trust calibration. A useful disagreement on whether primary care or specialty care will see the biggest near-term impact.